Amgen
Corporate Headquarters
One Amgen Center Drive
Thousand Oaks
California
91320-1799
United States
Tel: 805-447-1000
Fax: 805-447-1010
Website: http://careers.amgen.com/
Email: talentacquisitioninquiries@amgen.com
About Amgen
We are all different, yet we have this in common: our mission to serve patients. This sense of shared purpose is key to our becoming one of the world’s leading biotechnology companies. It guides us as we continue to launch new medicines and reach millions of patients worldwide.
We live the mission.
We win together.
We thrive on continual challenge.
Our team of 22,000+ scientists and professionals worldwide bring distinct perspectives and experiences to all we do. We leverage our global talent to achieve together—to research, manufacture and deliver ever-better products and greater depth to our mission.
At Amgen, there is a strong correlation between our high level of diversity and performance. Because addressing issues with a wider range of perspectives and approaches leads to more creative problem-solving. Together, we’re transforming the promise of science and biotechnology into therapies that have the power to restore health.
Connect with us to explore how you can Win, Live, and Thrive at Amgen.
Defy Imagination
2524 articles about Amgen
-
Amgen Announces Webcast of 2012 Second Quarter Financial Results
7/24/2012
-
Amgen Announces 2012 Third Quarter Dividend
7/23/2012
-
Array BioPharma, Inc. Reaches $8.5 Million Milestone in Amgen Diabetes Agreement
7/19/2012
-
Synthon Pharmaceuticals Enters Into Global License Agreement With Amgen and Watson Pharmaceuticals, Inc. for Biosimilar Trastuzumab
7/18/2012
-
Amgen Completes Acquisition of KAI Pharmaceuticals, Inc.
7/6/2012
-
NPS Pharmaceuticals, Inc. Rejiggers Amgen Deal, Sees $75 Million Extra Cash
7/2/2012
-
Actress Maura Tierney and Amgen Launch the Chemotherapy: Myths or Facts™ Campaign
6/25/2012
-
Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
6/13/2012
-
Supremes to Review Amgen Stock Fraud Case
6/12/2012
-
Amgen's Xgeva Wins U.K. National Institute for Clinical Excellence (NICE) Backing for Some Cancer Patients
6/12/2012
-
20th Annual Amgen Award For Science Teaching Excellence Honors Nine Outstanding Teachers
6/12/2012
-
Amgen Drug Sensipar Fails to Meet Trial Goal
6/11/2012
-
Amgen Announces Voting Results of Annual Meeting of Stockholders
5/24/2012
-
Amgen Revives Defunct Drug for New Cures
5/18/2012
-
Amgen's BiTE(R) Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
5/17/2012
-
Amgen to Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5/11/2012
-
Amgen Release: Cancer Support Community Launches National Program to Assist Patients With Cancer, Make Informed Decisions About Care
5/9/2012
-
Amgen to Present at the Baird Growth Stock Conference
5/7/2012
-
Amgen to Present at the Deutsche Bank 37th Annual Healthcare Conference
5/4/2012
-
FDA Rejects Amgen's Application for Xgeva
5/1/2012